📊 Score Breakdown
Offering Ability
90
Cash Runway
25
Float Risk
30
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
26%
📉 Score Deterioration
40%
• Score rose 27 points recently (worsening)
💰 Capital Raise
20%
• Active shelf registration ($100M, 291% of market cap)
💹 Market Data
Market Cap$34.32M
Shares Outstanding7.85M
Float7.78M
Cash$12.97M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
8.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short Interest1.74M
Days to Cover2.4
% of Float22.3%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2024
xbrl
XBRL CONVERTIBLE
Dec 31, 2023
EFFECT
EFFECT
Feb 17, 2026
S-3
SHELF
Feb 11, 2026
3
FORM3
Jan 30, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for QCLS
📊 QCLS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 QCLS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.